Work

Faculty Opinions recommendation of Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome.

Year: 2017

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.727343869.793532213

Author: Fabio Candotti

Institution: Centre Hospitalier Universitaire Vaudois

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4252103971

Cites:

Cited by:

Related to: 10